In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
COVID cases in our region are increasing. Over the past two weeks to 5 December 2021 there have been 954 locally acquired cases in the CESPHN region, a 29% per cent increase over the previous period. The largest concentrations are in the LGAs of Canterbury-Bankstown (158), Sydney (141), Randwick (133), Sutherland (101) and Waverley (100). The omicron variant of COVID-19 has been detected in our region.
See here for information on the latest testing locations. Please remember to refer your patients to a GP respiratory clinic if they need a respiratory assessment. You can find contact details here.
COVID care in the community
People who are COVID positive and who are assessed by the local health districts as low to medium risk can be managed at home under the care of their usual general practice via telehealth. The processes for managing COVID positive patients in the community are fully outlined in HealthPathways. See links below.
For more information join the next RACGP/NSW Health COVID-19 update to hear the latest news about the omicron variant, the efficacy of the vaccines, the role of GPs going forward and how HealthPathways can support GPs in NSW to care for COVID-19 positive patients in the community.
When: Monday, 13 December 2021, 7.00-8.30 pm Register here
Presenters: Dr Kerry Chant, Dr Amith Shetty, Dr Bettina McMahon, Dr Louise Delaney, Assoc Prof Charlotte Hespe and Dr Wally Jammal.
Vaccination update
Within the region 87% of the population aged 15 and over have received one vaccine dose and 86% are fully vaccinated (a 1% increase from last week). 13% of the population remain unvaccinated.
Please continue to contact our practice support team via coronavirus@cesphn.com.au should you wish to transfer vaccine. We note many practices have established local arrangements to share vaccine while demand is low.
Vaccinating practices who would like to order smaller doses of Pfizer vaccine are asked to contact the PHN. If you would like to deliver the Moderna vaccine please also contact coronavirus@cesphn.com.au.
General practices and pharmacists are encouraged to review their patients and identify those who are unvaccinated or need a booster dose and arrange COVID-19 vaccination for them.
Schools in our region are being impacted by COVID outbreaks – it’s important that general practice be aware of the COVID-19 response protocols in schools – see Schools and Covid protocol – advice to families.
TGA provisionally approves Pfizer for 5 to 11 year-olds
The TGA has now provisionally approved the Pfizer COVID-19 vaccine as a safe and effective vaccine for 5 to 11 year-olds. The first shipment of children’s doses is due to arrive in Australia by early January 2022 and will undergo the same rigorous batch testing processes in the TGA laboratories as other batches of COVID-19 vaccines.
Subject to final considerations and recommendations from the vaccination experts on the Australian Technical Advisory Group on Immunisation (ATAGI), and other related approvals, the Australian Government will start rolling out the Pfizer vaccine to 5 to 11-year-olds from 10 January 2022. Read full media release.
Additional training (online module) will be required before general practices can administer the Pfizer vaccine to children.
COVID-19 booster dose intervals
A booster dose is available to anyone in Australia aged 18 years and over who has completed their primary course of vaccination at least six months ago. The ATAGI has advised that in special circumstances, the six-month interval may be shortened to five months when needed for logistical reasons, for example:
for patients with a greater risk of severe COVID-19 in outbreak settings;
if an individual is travelling overseas and will be away when their booster dose is due; or
in outreach vaccination programs where access is limited.
Providers should use their clinical judgement to determine whether it is appropriate to administer the dose early. It should be noted that there are very limited data on benefit for boosters given prior to 20 weeks after completion of the primary course, and the duration of protection following boosters is not yet known. See full ATAGI clinical guidance on COVID-19 vaccines.
COVID-19 webinars
Live stream update for GPs: The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout. Get involved by submitting questions and comments! Details: Thursday, 9 December, 11.30 am (AEDT) | Click link to join
Easy Read resources for people with intellectual disability
The Department of Health has published three new Easy Read resources on the booster dose, third dose and the difference between them. These are useful resources for having conversations with people with intellectual disability, explaining the updated advice on booster dose. The Department of Health has also published an Easy Read Consent Form for use with people with intellectual disability.
Free infection control advice
CESPHN is pleased to offer general practices, community pharmacies and allied health the opportunity to have a specialised one-on-one consultation session with an experienced primary care infection control educator. This consult will enable your practice/pharmacy to:
Send questions prior to the consultation session about your practice
Ask questions on infection control that relates to your practice.
Sessions will be via ‘Zoom’ and will be up to 50 minutes in duration and can be recorded for later use. The aim of these sessions is to support practices and community pharmacies to ensure they have the strongest infection procedures in place and provide tips for improvement where needed. If you would like more information or would like to book a consultation, please email your interest to coronavirus@cesphn.com.au and in the subject line write: “Yes I would like infection control advice”.
Additional PPE available
Personal Protective Equipment (PPE) packages including surgical and N95/P2 masks, is available for community pharmacies and those GPs who continue to see their patients within their practices. PPE guidelines can be found here. CESPHN will continue to distribute these supplies. To order PPE for your practice or pharmacy click here.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
COVID-19 weekly update – 02 JANUARY 2023 COVID-19 cases in the region Please note: From next week the latest COVID-19 information will be included in the Sydney Health Weekly newsletter, rather than separated at the top. We will still provide COVID-19 related information as well as the dedicated COVID-19 latest…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. Randwick scientist and grandmother Hilda Stender shared this: What exercise did you do yesterday? I’ve had two knee replacements – one four years ago and the other six months ago. As a result,…
Immunisation weekly update – 1 February 2023 Childhood immunisation overdue reports CESPHN is inviting general practices to sign up to receive a regular report extracted on your behalf from the Australian Immunisation Register (AIR) which is specific to your practice. This report contains all children aged 0-5 living in the CESPHN region…
Australian Digital Health Agency (ADHA) digital health webinars Implementing MyHealth Record Policies in your organisation Thu 9 Feb 23, 12.30-1.00 pm – learn how to implement and maintain a My Health Record Security and Access policy in your organisation. Understand the importance of the Responsible Officer (RO) and Organisational Maintenance…
UNSW research – Palliative care and intellectual disability A research team led by Professor Julian Trollor at the Department of Developmental Disability Neuropsychiatry, UNSW Sydney, aims to design, implement, and evaluate a new palliative care service for people with intellectual disability. This is important because people with intellectual disability often…
GP support needed: Shared e-Care plan study for follow-up of colorectal and breast cancers This research evaluates shared care using a new interactive e-care plan being implemented through cancer services in Prince of Wales and St George public and private hospitals. Through the e-care plan GPs, cancer specialists and patients…